R Kálmánchey1, L Szücs, K Majtényi
1Semmelweis OTE II, Gyermekklinika.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Non-ketotic hyperglycinaemia (NKH) in three children is detailed. NMDA-antagonist drugs improved clinical outcomes in two patients, suggesting a potential therapeutic avenue for this rare metabolic disorder.
Area of Science:
Background:
Observation:
Findings:
Implications: